medicine-news-1/statement-regarding-cardinal-rigalis-memo-protecting-the-status-quo-on-life-60897-2/;+scheduling.html

Breaking Biology Technology:Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 2 Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 3 Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 4 Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 5 Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 6 MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products 2 MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products 3 MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products 4 CSOFT's MedL10N Hires Beckman Coulter Veteran Tammy Werner 2 CSOFT's MedL10N Hires Beckman Coulter Veteran Tammy Werner 3 Dendreon Announces Proposed Public Offering of Common Stock 2 Dendreon Announces Proposed Public Offering of Common Stock 3

[0] Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain [0] MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products [0] CSOFT's MedL10N Hires Beckman Coulter Veteran Tammy Werner [0] Dendreon Announces Proposed Public Offering of Common Stock

Breaking Medicine Technology:China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2 China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3 China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4 China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5 China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6 China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7 China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8 OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 2 OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 3 OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 4 Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 2 Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 3 Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 4 MTVS GYT Campaign Spurs Nationwide Movement to Get Yourself Tested 47670 1 MTVS GYT Campaign Spurs Nationwide Movement to Get Yourself Tested 47670 2 MTVS GYT Campaign Spurs Nationwide Movement to Get Yourself Tested 47670 3 MTVS GYT Campaign Spurs Nationwide Movement to Get Yourself Tested 47670 4 MTVS GYT Campaign Spurs Nationwide Movement to Get Yourself Tested 47670 5 MTVS GYT Campaign Spurs Nationwide Movement to Get Yourself Tested 47670 6 Astellas Hires New Vice President of Compliance 47666 1 Astellas Hires New Vice President of Compliance 47666 2 Scientists use bed bugs own chemistry against them 47664 1 Scientists use bed bugs own chemistry against them 47664 2 Scientists use bed bugs own chemistry against them 47664 3 Scientists use bed bugs own chemistry against them 47664 4

[0] China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 [0] OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months [0] Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation